Pneumosystis Carinii RNA Detection Qualitative Test
Cost: AED 1700.0
Test Name:
Pneumosystis Carinii RNA Detection Qualitative Test
Components:
Price: AED 1700.0
Sample Condition: fresh tissue biopsy specimens, skin biopsy specimen from a patient with disseminated nodular skin lesions, tissue specimens from a variety of body sites (brain, skin and soft tissue, eye, bone, lung, cardiac valve, and bone marrow), peripheral blood specimens, respiratory secretions.
Report Delivery:
4th Working Day Email: 48 hours
On phone: 36 hours
Method:
Real Time RT-PCR
Test Type:
Viral
Doctor:
Physician
Test Department:
Genetics
Pre Test Information:
Need to sign Consent document and bring any clinical history of patient for Pneumosystis Carinii (RNA Detection) Qualitative Test
Test Details:
The Pneumocystis carinii (now known as Pneumocystis jirovecii) RNA detection qualitative test is a diagnostic test used to detect the presence of Pneumocystis jirovecii in respiratory samples. Pneumocystis jirovecii is a fungus that can cause a severe form of pneumonia, especially in individuals with weakened immune systems, such as those with HIV/AIDS.
The test uses molecular techniques, such as polymerase chain reaction (PCR), to amplify and detect the RNA (genetic material) of the fungus. It is a highly sensitive and specific test that can detect even small amounts of Pneumocystis jirovecii in respiratory samples, such as sputum, bronchoalveolar lavage fluid, or lung tissue.
The qualitative nature of the test means that it provides a “yes” or “no” answer regarding the presence of Pneumocystis jirovecii in the sample. A positive result indicates the presence of the fungus, confirming the diagnosis of Pneumocystis pneumonia. A negative result suggests the absence of the fungus, although it is important to note that false-negative results can occur due to various factors, such as low levels of the fungus in the sample or issues with the testing process.
The Pneumocystis jirovecii RNA detection qualitative test is an important tool in diagnosing Pneumocystis pneumonia, guiding appropriate treatment, and monitoring response to therapy. It is typically performed in specialized laboratories and requires trained personnel to perform and interpret the results accurately.
| Test Name | Pneumosystis Carinii RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 1700.0 AED |
| Sample Condition | fresh tissue biopsy specimens, skin biopsy specimen from a patient with disseminated nodular skin lesions, tissue specimens from a variety of body sites (brain, skin and soft tissue, eye, bone, lung, cardiac valve, and bone marrow), peripheral blood specimens, respiratory secretions. |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time RT- PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forPneumosystis Carinii (RNA Detection) QualitativeTest |
| Test Details |
The Pneumocystis carinii (now known as Pneumocystis jirovecii) RNA detection qualitative test is a diagnostic test used to detect the presence of Pneumocystis jirovecii in respiratory samples. Pneumocystis jirovecii is a fungus that can cause a severe form of pneumonia, especially in individuals with weakened immune systems, such as those with HIV/AIDS. The test uses molecular techniques, such as polymerase chain reaction (PCR), to amplify and detect the RNA (genetic material) of the fungus. It is a highly sensitive and specific test that can detect even small amounts of Pneumocystis jirovecii in respiratory samples, such as sputum, bronchoalveolar lavage fluid, or lung tissue. The qualitative nature of the test means that it provides a “yes” or “no” answer regarding the presence of Pneumocystis jirovecii in the sample. A positive result indicates the presence of the fungus, confirming the diagnosis of Pneumocystis pneumonia. A negative result suggests the absence of the fungus, although it is important to note that false-negative results can occur due to various factors, such as low levels of the fungus in the sample or issues with the testing process. The Pneumocystis jirovecii RNA detection qualitative test is an important tool in diagnosing Pneumocystis pneumonia, guiding appropriate treatment, and monitoring response to therapy. It is typically performed in specialized laboratories and requires trained personnel to perform and interpret the results accurately. |
